Finance

Lists
PHAT:NASDAQ
Phathom Pharmaceuticals Inc
၅.၁၆ US$
+၁.၅၇%
(+၀.၀၈၀) 1D
နို ၆, GMT-၅ ၁၄:၁၁:၅၉  ·   USD
All symbols
SymbolPriceChange% Change
Generating top insights for PHAT...
Open
၅.၂၆ US$
High
၅.၃၀ US$
Low
၅.၀၄ US$
Mkt. cap
၄၁.၉၅ ကုဋေ
Avg. vol.
၁.၆၅ သန်း
Volume
၁.၀၉ သန်း
52-wk high
၁၈.၃၁ US$
52-wk low
၅.၀၂ US$
EPS
-၁.၀၃ US$
Beta
၀.၆၉
Shares outstanding
၈.၁၃ ကုဋေ
No. of employees
၃၇၁
Open
၅.၂၆ US$
High
၅.၃၀ US$
Low
၅.၀၄ US$
Mkt. cap
၄၁.၉၅ ကုဋေ
Avg. vol.
၁.၆၅ သန်း
Volume
၁.၀၉ သန်း
52-wk high
၁၈.၃၁ US$
52-wk low
၅.၀၂ US$
EPS
-၁.၀၃ US$
Beta
၀.၆၉
Shares outstanding
၈.၁၃ ကုဋေ
No. of employees
၃၇၁
News stories
From web sources and news partners
Zacks
Zacks
·
ပြီးခဲ့သည့် ၅ နာရီ
Implied Volatility Surging for Phathom Pharmaceuticals Stock Options
Yahoo Finance
Yahoo Finance
·
ပြီးခဲ့သည့် ၆ နာရီ
Implied Volatility Surging for Phathom Pharmaceuticals Stock Options
About Phathom Pharmaceuticals Inc
CEO-
Employees၃၇၁
Founded၂၀၁၈
HeadquartersFlorham Park, နယူးဂျာစီပြည်နယ်, ယူနိုက်တက်စတိတ်
SectorHealth Care
Industry-
Analyst ratings
Based on 6 analysts giving stock ratings to PHAT in the past 3 months
Strong buy
Buy
5
Hold
1
Sell
0
12-month forecast
Based on 6 Wall Street analysts offering 12 month price targets for PHAT in the last 3 months.
Highest
Current ၅.၁၆ US$
၂၆.၀၀ US$ (+၄၀၃.၈၈%)
Average
၁၆.၉၀ US$ (+၂၂၇.၅၂%)
Lowest
၇.၅၀ US$ (+၄၅.၃၅%)
Analyst
Recommendation
Action
Price target
Projected
Date
Daniel Clark
Leerink Partners
Hold
Maintained
၇.၅၀ US$
+၄၅.၃%
11/02/2026
Yatin Suneja
Guggenheim
Buy
Reiterated
၂၂.၀၀ US$
+၃၂၆.၄%
10/29/2026
Matthew Caufield
H.C. Wainwright
Buy
Reiterated
၂၆.၀၀ US$
+၄၀၃.၉%
10/30/2026
Jenna Davidner
Barclays
Buy
Maintained
၁၄.၀၀ US$
+၁၇၁.၃%
10/30/2026
Kristen Kluska
Cantor Fitzgerald
Buy
Maintained
-
-
10/23/2026
Chase Knickerbocker
Craig-Hallum
Buy
Maintained
၁၅.၀၀ US$
+၁၉၀.၇%
10/21/2026
Martin Auster
Raymond James
Buy
Maintained
၂၁.၀၀ US$
+၃၀၇%
07/31/2026
Joseph Stringer
Needham
Buy
Maintained
၂၂.၀၀ US$
+၃၂၆.၄%
07/30/2026
Paul Choi
Goldman Sachs
Hold
Maintained
-
-
04/30/2026
Last report
၂၀၂၆ အောက် ၂၉
Fiscal period
Q3 2026
၀.၀၄ US$ / ၀.၀၃ US$
+၃၉.၈၆%beat
Revenue / Est. (USD)
၈.၄၇ ကုဋေ / ၈.၄၈ ကုဋေ
-၀.၁၂%miss
Fiscal Q3 2026 earnings call
Waiting for the earnings call
At a glance
Insights from the latest news and reports
Previous reportsAll values in USD
Loading Previous Earnings...
Revenue
Net income
All values in USD
၂၀၂၅ ဒီ
၂၀၂၆ မတ်
၂၀၂၆ ဇွန်
၂၀၂၆ စက်
Revenue
၅.၇၆ ကုဋေ
၅.၈၃ ကုဋေ
၇.၄၃ ကုဋေ
၈.၄၇ ကုဋေ
Cost of goods sold
၇.၆၅ သန်း
၁.၂၀ ကုဋေ
၁.၅၁ ကုဋေ
၁.၈၄ ကုဋေ
Cost of revenue
၇.၆၅ သန်း
၁.၂၀ ကုဋေ
၁.၅၁ ကုဋေ
၁.၈၄ ကုဋေ
Research and development expenses
၇.၄၉ သန်း
၇.၇၇ သန်း
၇.၈၁ သန်း
၈.၇၄ သန်း
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
၄.၈၄ ကုဋေ
၅.၄၀ ကုဋေ
၅.၅၃ ကုဋေ
၅.၇၇ ကုဋေ
Operating expense
၅.၅၉ ကုဋေ
၆.၁၈ ကုဋေ
၆.၃၁ ကုဋေ
၆.၆၄ ကုဋေ
Total operating expenses
၆.၃၅ ကုဋေ
၇.၃၈ ကုဋေ
၇.၈၂ ကုဋေ
၈.၄၈ ကုဋေ
Operating income
-၅.၉၃ သန်း
-၁.၅၅ ကုဋေ
-၃.၉၆ သန်း
-၈.၅၀ သောင်း
Other non operating income
-၅.၀၀ ထောင်
-၈.၃၁ သိန်း
-၂.၄၀ သောင်း
-၂.၅၀ သောင်း
EBT including unusual items
-၂.၁၁ ကုဋေ
-၃.၀၄ ကုဋေ
-၁.၇၆ ကုဋေ
-၁.၃၉ ကုဋေ
EBT excluding unusual items
-၂.၁၁ ကုဋေ
-၃.၀၄ ကုဋေ
-၁.၇၆ ကုဋေ
-၁.၃၉ ကုဋေ
Income tax expense
-
-
-
-
Effective tax rate
-
-
-
-
Other operating expenses
-
-
-
-
Net income
-၂.၁၁ ကုဋေ
-၃.၀၄ ကုဋေ
-၁.၇၆ ကုဋေ
-၁.၃၉ ကုဋေ
Net profit margin
-၃၆.၇၃%
-၅၂.၀၉%
-၂၃.၆၇%
-၁၆.၄၀%
Earnings per share
-၀.၀၈
-၀.၁၈
-
၀.၀၄
Interest and investment income
၁.၂၀ သန်း
၁.၇၄ သန်း
၁.၅၁ သန်း
၁.၆၀ သန်း
Interest expense
-၁.၆၄ ကုဋေ
-၁.၅၈ ကုဋေ
-၁.၅၁ ကုဋေ
-၁.၅၄ ကုဋေ
Net interest expenses
-၁.၅၂ ကုဋေ
-၁.၄၁ ကုဋေ
-၁.၃၆ ကုဋေ
-၁.၃၈ ကုဋေ
Depreciation and amortization charges
-
-
-
-
EBITDA
-၅.၈၀ သန်း
-၁.၅၄ ကုဋေ
-၃.၈၅ သန်း
၃.၅၀ သောင်း
Gain or loss from assets sale
-
-
-
-
Insider transactions
Insider transactions data is drawn from third-party sources. Learn more
Insider
Position
Type
Date
Shares
Amount
Page 1
Upcoming events
AI content may include mistakes. Learn more
Google အက်ပ်များ